LIF and breast cancer: In addition, an ex-vivo correlation has been established, showing that breast cancer tissue sections from patients exhibit differential expression of the iCAF marker (LIF) (59–61), and the myoCAF marker (αSMA), depending on their obesity status (59, 62, 63).